Zentalis Pharmaceuticals ... (ZNTL)

1.92

-0.15 (-7.25%)

At close: Mar 03, 2025, 3:59 PM

1.86

-3.03%

After-hours: Mar 03, 2025, 04:09 PM EST

Zentalis Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-292.19M	-237.11M	-166.09M	-118.55M	-46.38M	-23.43M
Depreciation & Amortization	1.39M	1.43M	544K	160K	111K	51K
Stock-Based Compensation	54.82M	46.84M	35.74M	23.15M	617K	308K
Other Working Capital	-5.05M	-2.27M	1.35M	-667K	115K	-40K
Other Non-Cash Items	23.15M	12.61M	-38.38M	556K	-7.78M	-2.37M
Deferred Income Tax	-853K	-769K	-2.46M	17K	7.78M	2.37M
Change in Working Capital	5.86M	13.25M	16.56M	7.84M	6.51M	-1.18M
Operating Cash Flow	-207.82M	-163.75M	-154.09M	-86.83M	-39.14M	-24.25M
Capital Expenditures	-583K	-2.55M	-6.11M	-758K	-352K	-227K
Acquisitions	n/a	111.63K	-14.32M	18.42M	n/a	n/a
Purchase of Investments	-549.18M	-533.16M	-363.51M	-400.98M	n/a	n/a
Sales Maturities Of Investments	505.31M	421.53M	365.82M	116.91M	n/a	n/a
Other Investing Acitivies	n/a	-111.63K	-12.01K	-18.42M	n/a	n/a
Investing Cash Flow	-44.46M	-114.18M	-18.11M	-284.83M	-352K	-227K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-1.15M	32.65M	81.83M	9.46M
Financial Cash Flow	237.3M	261.04M	178.52M	360.44M	81.83M	9.47M
Net Cash Flow	-14.98M	-16.89M	6.31M	-11.22M	42.34M	-15.01M
Free Cash Flow	-208.41M	-166.3M	-160.2M	-87.58M	-39.49M	-24.48M